Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Delphia is leading the way in a groundbreaking field of cancer biology known as activation lethality, aiming to revolutionize cancer treatment and enhance patient outcomes. Despite significant progress in targeting driver mutations in oncogenes, cancer remains a formidable global health concern due to the rapid emergence of therapy resistance in most patients. Delphia's activation lethality platform presents a promising opport...
Delphia is leading the way in a groundbreaking field of cancer biology known as activation lethality, aiming to revolutionize cancer treatment and enhance patient outcomes. Despite significant progress in targeting driver mutations in oncogenes, cancer remains a formidable global health concern due to the rapid emergence of therapy resistance in most patients. Delphia's activation lethality platform presents a promising opportunity for novel cancer medications that not only work independently but also counteract the development of resistance to traditional targeted treatments.

List your booth number for exhibitions, ask us